FDA Makes New Recommendations on Contact Lens Solution Labeling

Search

Topics

Uncategorized

Links
- FDA

Case Review Form

* Denotes required field.

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of injured person
(mm-dd-yyyy):

Name of medical device:

Please describe any problems or injuries caused by the device:

Other Info:

No Yes, I agree to the Parker & Waichman, LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker & Waichman, LLP monthly newsletter, InjuryAlert.

Archives

Latest Medical Device News

Abiomed AB5000 Circulatory Support System: Class I Recall - Device computer may shut down without an alarm, which can lead to serious injuries or death.
Avandia (rosiglitazone): Ongoing Review of Cardiovascular Safety - FDA is reviewing data from a large, long-term clinical study on possible risks for cardiovascular outcomes associated with use of rosiglitazone.
BD Q-Syte Luer Access Devices: Recall - Device may cause an air embolism or leakage of blood and/or therapy, which may result in serious injury or death.
Baxter HomeChoice and HomeChoice PRO Automated Peritoneal Dialysis Systems: Class I Recall - Reports of serious injuries and at least one death have been associated with increased Intraperitoneal Volume (IIPV), also known as overfill of the abdominal cavity.
Beckman Coulter UniCel DxC Synchron Clinical System – Ion Selective Electrode Flow Cell: Class I Recall - Incorrect sodium results may be caused by build-up of protein, bacteria, and sample tube additives in the ion selective electrode flow cell.
Cardiac Science Automated External Defibrillators (Powerheart, Cardiovive, CardioLife, NK, Responder models): Class I Recall - UPDATED 03/08/2010: Recall classified as Class I, expanded list of affected models. Originally posted 02/09/2010
Ear Candles: Risk of Serious Injuries - Consumers warned not to use ear candles because they can cause serious injuries, even when used according to the manufacturer’s directions.
Erythropoiesis-Stimulating Agents (ESAs): Procrit, Epogen and Aranesp: Drug Safety Communication - FDA requires REMS that ensures that only those hospitals and healthcare professionals who have enrolled and completed training in risk management program will prescribe and dispense ESAs to patients with cancer.
Exjade (deferasirox): Boxed Warning - Changes to Prescribing Information re: risk of renal impairment/failure, hepatic impairment/failure or gastrointestinal hemorrhage.
Invirase (saquinavir): Ongoing safety review of clinical trial data - Possible association with abnormal heart rhythms when used in combination with Norvir (ritonavir).
Long-Acting Beta-Agonists (LABAs): New Safe Use Requirements - FDA requires risk management plan and class-labeling changes for all LABAs.
Maalox Total Relief and Maalox Liquid Products: Medication Use Errors - Consumers who have a history of gastrointestinal ulcers or a bleeding disorder should not use Maalox Total Relief because it contains bismuth subsalicylate, a substance chemically related to aspirin.
OneTouch SureStep Test Strips (LifeScan): Recall - Test strips are being recalled because they may provide falsely low glucose results when the glucose level is higher than 400 mg/dL.
Oral Bisphosphonates: Ongoing Safety Review of Atypical Subtrochanteric Femur Fractures - FDA review of available data have not shown a clear connection between bisphosphonate use and a risk of atypical subtrochanteric femur fractures.
Safesheath CSG Coronary Sinus Guide Hemostatic Introducer System with Infusion Sideport by Thomas Medical - Sheath tip may break off and separate while the sheath is inside a blood vessel, leading to serious injury or death.
StatSpin Express 4 Centrifuges Model 510: Class I Recall - Rotor may break and eject pieces of the rotor which may cause serious physical injury to bystanders and expose them to blood-borne infectious micro-organisms.
Thomas Medical Products, Inc., Transseptal Sheath Introducer Kits: Class I Recall - Sheath tip may break off and separate during heart procedures, causing a blockage that could lead to permanent injury and/or death.
Tysabri (Natalizumab): Update of Healthcare Professional Information - Risk of developing progressive multifocal leukoencephalopathy (PML) increases with increasing duration of exposure to Tysabri.
WinRho SDF (Rho(D) Immune Globulin Intravenous (Human): Risk of Intravascular Hemolysis - Cases of intravascular hemolysis and its complications have been reported in patients treated for immune thrombocytopenic purpura with WinRho.
Zyprexa (olanzapine): Use in Adolescents - Clinicians should consider the potential long-term risks when prescribing to adolescents.

FDA Makes New Recommendations on Contact Lens Solution Labeling

June 18th, 2009 meg

The FDA has convened a workshop to develop consensus on test methods for evaluating contact lens solutions.

Based on the workshop and a meeting of advisors, the FDA is developing manufacturer guidelines on potential labeling improvements for these products.

The advisory panel for ophthalmic devices made specific recommendations, including a discard date on their products, in addition to the usual expiration date. The discard date is the date the solution should be thrown out after opening.

The panel also concluded that there is still improvement in lens care when using a rub-and-rinse regimen as compared to a rinse-alone regimen, which some manufacturers market as a “no-rub” solution.

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.